MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-01-0010642
Watran Pharmaceuticals Private Limited - pharma in Ambala, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.42 Cr
▲ 24% YoY
Net profit · FY 2025
₹10.94 Lakh
Net margin 1.3%
EBITDA · FY 2025
₹42.31 Lakh
EBITDA margin 5%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Open charges
₹71.45 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
About Watran Pharmaceuticals Private Limited
Data last updated:
Watran Pharmaceuticals Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24304HR2019PTC080095. Its GSTIN is 06AACCW4245N1Z0 (Haryana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Sachin Kumar and Reena Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at V – Dera Tehsil Naraingarh District Ambala, Haryana, India – 134203.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.42 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹10.94 Lakh (net margin 1.3%) and EBITDA of ₹42.31 Lakh (EBITDA margin 5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 54% over five years.
The company is associated with 1 brand: Watran Pharmaceuticals. As per MCA filings, the company has open charges of ₹71.45 Lakh on record. Court records list 6 cases involving the company, including 4 filed by the company and 2 filed against it; 4 cases are pending.
Watran Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0010642). For more details, the company can be reached via its website watranpharmaceuticals.com.
Company details
CIN U24304HR2019PTC080095
Registration Number 080095
Incorporation Date 02 May 2019
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-HR-01-0010642
Recognitions & Rankings of Watran Pharmaceuticals
Contact details
Watran Pharmaceuticals Private Limited's registered office is in Ambala, Haryana. Its website is watranpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressV – Dera Tehsil Naraingarh District Ambala, Haryana, India – 134203
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Watran Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Watran Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Watran Pharmaceuticals operates one associated brand: Watran Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, franchise services, and third-party production in India. | watranpharmaceuticals.com |
Business activity
The main business activity of Watran Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Watran Pharmaceuticals Private Limited, buy the company report.
Financials of Watran Pharmaceuticals Private Limited
FY 2025 filings availableWatran Pharmaceuticals Private Limited reported revenue of ₹8.42 Cr (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹8.42 Cr ▲ 24%
Net profit · FY 2025
₹10.94 Lakh margin 1.3%
EBITDA · FY 2025
₹42.31 Lakh margin 5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 7%
5 years · compounded
▲ 54%
EBITDA CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 34%
5 years · compounded
▲ 75%
Revenue has grown at a compounded annual rate (CAGR) of 54% over five years, including 24% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹42.31 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.94 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Watran Pharmaceuticals Private Limited, buy the company report.
Board of directors of Watran Pharmaceuticals Private Limited
Watran Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Kumar Also directs: Alfavision Biotech Private Limited | Director | 19 Oct 2023 | 3 Years 0 Months | Current |
| Reena Rani Also directs: Aconwell Pharma Private Limited | Director | 15 Nov 2025 | 0 Years 11 Months | Current |
| Manjeet Kaur | Director | 15 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Watran Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rivan Pharmaceuticals Private Limited | ₹8.53 Cr (FY 2025) | -2.0% | Ahmedabad, Gujarat, India | |||
| Takeda Pharmaceuticals India Private Limited | ₹8.48 Cr (FY 2022) | -2.0% | Bhiwandi, Maharashtra, India | |||
| Zenitiva Pharmaceuticals India Private Limited | ₹8.48 Cr (FY 2025) | 12.0% | Delhi, India | |||
| Neomac Pharmaceuticals Private Limited | ₹8.43 Cr (FY 2024) | 21.0% | Amritsar, Punjab, India | |||
| Litex Pharmaceuticals Private Limited | ₹8.43 Cr (FY 2024) | 18.0% | Delhi, India | |||
| Watran Pharmaceuticals Private Limitedthis company | ₹8.42 Cr (FY 2025) | ₹10.94 Lakh | 1.3% | 24.0% | Ambala, Haryana, India | |
| Scitex Pharmaceuticals Private Limited | ₹8.31 Cr (FY 2024) | 2985.0% | Medchal, Telangana, India | |||
| Deepar Pharmaceuticals Private Limited | ₹8.3 Cr (FY 2025) | 6.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Watran Pharmaceuticals Private Limited, buy the company report.
Auditor
Watran Pharmaceuticals Private Limited is audited by GOYAL JYOTI & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOYAL JYOTI & COMPANY | FY 2023 | 539129 |
Shareholding
The shareholding of Watran Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Watran Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹71.45 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Oct 2022 | 100624694 | Hdfc Bank Limited | ₹21.45 Lakh | Open | |
| 31 Jan 2022 | 100547199 | Others | ₹50 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Watran Pharmaceuticals Private Limited has 6 court cases on record: 4 filed by Watran Pharmaceuticals, 2 filed against it. 4 cases are pending and 2 are disposed.
Total cases
6
Filed by the company
4
Filed against the company
2
Pending
4
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 4 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (COMIP) | Filed against the company by Franco Indian Pharmaceuticals Private Limited | Disposed |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Franco Indian Pharmaceuticals Private Limited | Disposed |
| District court, Sirmaur, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against M/S Vijay Drugs Distributor and 1 other | Pending |
| District court, Sirmaur, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against M/S Lumin Healthcare and 1 other | Pending |
| District court, Sirmaur, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against M/S Wallcott Pharma | Pending |
To see the full case history of Watran Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Watran Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Watran Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AACCW4245N1Z0 | Haryana | Active | 25 May 2019 |
To see the full GST registrations and return filing status of Watran Pharmaceuticals Private Limited, buy the company report.
Recent activity
Watran Pharmaceuticals Private Limited has 7 board changes on record since 2023: 3 appointments and 4 cessations. The latest: Manjeet Kaur was appointed as Director on 15 Nov 2025.
Appointed
Manjeet Kaur was appointed as Director.
Appointed
Reena Rani was appointed as Director.
AGM
Watran Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Watran Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Ceased
Abhiraj Sandhu ceased to be Director.
Ceased
Jitender Singh ceased to be Director.
Ceased
Sujata . ceased to be Director.
Ceased
Sunita ceased to be Director.
Appointed
Sachin Kumar was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 21.45 Lakh with Charge ID 100624694 was registered on 04 Oct 2022.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 100547199 was registered on 31 Jan 2022.
Incorporation
02 May 2019
Watran Pharmaceuticals Private Limited was registered on 02 May 2019 with Roc Haryana & aged 7 years 6 months as per MCA records.
Frequently asked questions
Watran Pharmaceuticals is an active private limited company based in Ambala, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 May 2019 (7+ years old) and is registered under CIN U24304HR2019PTC080095.
Watran Pharmaceuticals has 3 current directors:
- Sachin Kumar - Director
- Reena Rani - Director
- Manjeet Kaur - Director
The latest financial statements of Watran Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Watran Pharmaceuticals is 06AACCW4245N1Z0, registered in Haryana.
The CIN (Corporate Identification Number) of Watran Pharmaceuticals is U24304HR2019PTC080095. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Watran Pharmaceuticals has 6 court cases on record: 4 filed by the company and 2 filed against it. 4 are pending. Most are in the district courts.
Watran Pharmaceuticals was incorporated on 02 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Watran Pharmaceuticals by revenue are Rivan Pharmaceuticals Private Limited, Takeda Pharmaceuticals India Private Limited, Zenitiva Pharmaceuticals India Private Limited, Neomac Pharmaceuticals Private Limited, Litex Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Manjeet Kaur was appointed as Director on 15 Nov 2025. Reena Rani was appointed as Director on 15 Nov 2025. Abhiraj Sandhu ceased to be Director on 29 May 2024. Watran Pharmaceuticals has 7 board changes on record in total.
Yes, Watran Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-01-0010642).
Watran Pharmaceuticals can be reached through the website watranpharmaceuticals.com. Its registered office is in Ambala, Haryana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages